Computed Tomography (CT)
Latin America · 3 shared keywords
Updated
Reviewed by Chandani Patel
Latin America Nuclear Medicine Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.10 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $638.5 Mn | — | — |
| 2025 (base) | $708.7 Mn | +$70.2 Mn | — |
| 2026 (forecast) | $786.7 Mn | +$78.0 Mn | +11% |
| 2027 (forecast) | $873.2 Mn | +$86.5 Mn | +23.2% |
| 2028 (forecast) | $969.2 Mn | +$96.1 Mn | +36.8% |
| 2029 (forecast) | $1.08 Bn | +$106.6 Mn | +51.8% |
| 2030 (forecast) | $1.19 Bn | +$118.3 Mn | +68.5% |
| 2031 (forecast) | $1.33 Bn | +$131.4 Mn | +87% |
| 2032 (forecast) | $1.47 Bn | +$145.8 Mn | +107.6% |
| 2033 (forecast) | $1.63 Bn | +$161.9 Mn | +130.5% |
| 2034 (forecast) | $1.81 Bn | +$179.7 Mn | +155.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $708.7 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.81 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 11.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | GE Healthcare, Siemens Healthineers, Lantheus Holdings, Cardinal Health, Curium and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Nuclear medicine uses small amounts of radioactive tracers and special cameras to see how organs work and to treat some cancers.
Key segments of the nuclear medicine market include product (SPECT Systems, PET Systems and Diagnostic Radiotracers) and application (Oncology, Cardiology and Neurology).
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the nuclear medicine market. Clinicians also use imaging earlier in care.
AI-assisted reading, compact systems for clinics and the replacement of old scanners give the nuclear medicine market room to grow.
High equipment prices, a shortage of trained staff and long replacement cycles in public hospitals hold back the nuclear medicine market.
The nuclear medicine market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by ANVISA (Brazil)[1], ARCSA (Ecuador)[2], COFEPRIS (Mexico)[3], ANMAT (Argentina)[4], INVIMA (Colombia)[5] and ISP (Chile)[6]. How care is paid for in some of these countries: the SUS (Brazil)[7]; public care and IESS (Ecuador)[8]; IMSS, ISSSTE and IMSS-Bienestar (Mexico)[9]; public care, obras sociales and prepaid plans (Argentina)[10]; social health insurance (EPS) (Colombia)[11]; and FONASA and ISAPREs (Chile)[12].
[1] ANVISA. Checked 14 Nov 2026.
[2] ARCSA. Checked 14 Nov 2026.
[3] COFEPRIS. Checked 14 Nov 2026.
[4] ANMAT. Checked 19 Nov 2026.
[5] INVIMA. Checked 19 Nov 2026.
[6] Institute of Public Health of Chile (ISP). Checked 19 Nov 2026.
[7] CONITEC. Checked 14 Nov 2026.
[8] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.
[9] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
[10] Superintendence of Health Services (SSSalud). Checked 19 Nov 2026.
[11] Ministry of Health and Social Protection. Checked 19 Nov 2026.
[12] FONASA. Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how nuclear medicine products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Latin America.
From our blog
Latin America · 3 shared keywords
Latin America · 3 shared keywords
Latin America · 3 shared keywords
Latin America · 2 shared keywords
Latin America · 1 shared keyword
Latin America · 1 shared keyword
Digital Health · Latin America
Digital Health · Latin America
Digital Health · Latin America
Pharmaceuticals · Latin America
Pharmaceuticals · Latin America
Digital Health · Latin America